Joel S. Marcus - Mar 7, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Mar 7, 2022
Transactions value $
-$1,062,750
Form type
4
Date filed
3/9/2022, 08:49 PM
Previous filing
Jan 13, 2022
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Sale -$273K -5K -10.21% $54.52 44K Mar 7, 2022 Held by the Joel S. Marcus and Barbara A. Marcus Family Trust
transaction ITCI Common Stock Sale -$261K -5K -11.37% $52.25 39K Mar 8, 2022 Held by the Joel S. Marcus and Barbara A. Marcus Family Trust
transaction ITCI Common Stock Sale -$529K -10K -25.65% $52.89 29K Mar 8, 2022 Held by the Joel S. Marcus and Barbara A. Marcus Family Trust F1
holding ITCI Common Stock 13.8K Mar 7, 2022 Direct
holding ITCI Common Stock 26.9K Mar 7, 2022 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.72 to $53.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.

Remarks:

Excludes shares previously reported as indirectly held through Alexandria Venture Investments, LLC as it was subsequently determined that the Reporting Person does not have a reportable beneficial ownership interest in the securities held by such entity for purposes of Section 16.